Rabinowits, Guilherme <br/><br/>
Fixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neck.  [electronic resource] 

 -  The American journal of the medical sciences  Feb 2010 
 - 148-51 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1538-2990 
<br/><br/><label>Standard No.: </label>10.1097/MAJ.0b013e3181c4bd91  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Capecitabine<br/>Carcinoma, Squamous Cell--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Male<br/>Middle Aged<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Palliative Care<br/>Pilot Projects